The results of Olympus’ ongoing joint research program to create an AI-based pathology diagnostic tool with the potential to streamline
Continue reading »
Home »
Cancer: The ‘fleeting’ symptom that requires ‘urgent investigation’ – signs to look for
Dr Nighat discusses symptoms of prostate cancer We use your sign-up to provide content in ways you’ve consented to and
Continue reading »
Colorectal Cancer Rates Rising in People Aged 50 to 54 Years
New US data show that the incidence of colorectal cancer (CRC) is on the rise among people aged 50–54 years,
Continue reading »
Virtual lung cancer screening is just as effective as in-person screening
A novel telemedicine lung cancer screening effort during the COVID-19 pandemic shows that virtual single-visit screenings are just as effective
Continue reading »
NIH Head Collins Steps Down, Led Fight Against Cancer, COVID
WASHINGTON (AP) — Dr. Francis S. Collins, director of the National Institutes of Health for 12 years, said Tuesday he
Continue reading »
Study reveals the trends in recreational ketamine use and availability in the U.S.
Recreational ketamine use and availability of the drug have increased in recent years, but it remains an uncommon drug used
Continue reading »
Cancer chemotherapy drug reverses Alzheimer’s symptoms in mice
A drug commonly used to treat cancer can restore memory and cognitive function in mice that display symptoms of Alzheimer’s
Continue reading »
ACA Hardly Made a Dent in Catastrophic Cancer Costs
The enactment of the Patient Protection and Affordable Care Act (ACA) did not greatly reduce the risk for catastrophic health
Continue reading »
Penn Medicine and Wistar secure $11.7 million SPORE grant for three melanoma research projects
Penn Medicine and The Wistar Institute have been awarded a prestigious $11.7 million Specialized Programs of Research Excellence, or SPORE,
Continue reading »
Sunitinib extends progression-free survival in patients with rare neuroendocrine tumor, study shows
The first randomized study in malignant pheochromocytoma and paraganglioma (MPP) has found that sunitinib prolongs progression-free survival (PFS) by more
Continue reading »